What Is New in the Management of Skin and Soft Tissue Infections in 2016?

Garyphallia Poulakou; Efthymia Giannitsioti; Sotirios Tsiodras


Curr Opin Infect Dis. 2017;30(2):158-171. 

In This Article

Non-antimicrobial Therapy with Vaccines-phages

Bacteriophages (phages), against specific bacteria, are a promising novel therapeutic tool for ABSSSI or chronic skin infections that have not been extensively studied so far. A S.aureus-specific phage was successfully applied topically in a series of patients with chronic diabetic foot infections on ulcerated toes with osteomyelitis in a recent trial providing the groundwork for future randomized controlled clinical trials.[91]

Characteristics of agents in study or recently introduced in clinical practice are summarized in Table 4.[83,85,89,92–127]